Annual Drug Patent Expirations for ABRAXANE
Abraxane is a drug marketed by Bristol-myers and is included in one NDA. It is available from three suppliers. There are eleven patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for ABRAXANE.
The generic ingredient in ABRAXANE is paclitaxel. Three suppliers are listed for this compound. Additional details are available on the paclitaxel profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
